This production problem was also the cause of Illucix not getting approval initially. Just surprised that this happened again. Hopefully it won’t happens with their brain product which is yet to go thru its BLA application, Co. should makes extra attention to this besides the product efficacy. Don’t makes the same mistake again!
- Forums
- ASX - By Stock
- Ann: BLA Filing Update for Renal Cancer Imaging Agent TLX250-CDx
This production problem was also the cause of Illucix not...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$23.47 |
Change
0.130(0.56%) |
Mkt cap ! $7.855B |
Open | High | Low | Value | Volume |
$23.82 | $23.99 | $23.23 | $28.94M | 1.231M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2801 | $23.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$23.50 | 7000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2801 | 23.460 |
1 | 1000 | 23.450 |
1 | 2678 | 23.410 |
2 | 970 | 23.390 |
1 | 2678 | 23.380 |
Price($) | Vol. | No. |
---|---|---|
23.500 | 7000 | 1 |
23.580 | 1470 | 3 |
23.590 | 2678 | 1 |
23.620 | 5178 | 2 |
23.630 | 7680 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online